{"news_desk": "Business", "print_page": "5", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By CHAD BRAY", "person": [{"rank": 1, "role": "reported", "firstname": "Chad", "organization": "", "lastname": "BRAY"}]}, "abstract": "DealBook Online; Swedish Orphan Biovitrum says an unidentified suitor has sent preliminary takeover bid.", "type_of_material": "News", "word_count": "202", "lead_paragraph": "Swedish Orphan Biovitrum, which makes the ReFacto AF treatment for hemophilia for Pfizer, received a preliminary offer from an undisclosed suitor.", "pub_date": "2015-04-28T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Sobi, Swedish Maker of Drugs for Rare Diseases, Receives Takeover Bid", "print_headline": "Sobi Gets Offer"}, "snippet": "Swedish Orphan Biovitrum, which makes the ReFacto AF treatment for hemophilia for Pfizer, received a preliminary offer from an undisclosed suitor.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/04/28/business/dealbook/swedish-orphan-biovitrum-deal.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Swedish Orphan Biovitrum AB (Sobi)", "name": "organizations"}, {"rank": "2", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}], "blog": [], "_id": "553e18d338f0d8472d91b729", "source": "The New York Times"}